Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate Monotherapy Extension for Partial-Onset Seizures
NCT02484001Phase 3Completed
- Sponsor
- BIAL
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of eslicarbazepine acetate in focal onset seizure, sponsored by BIAL. Started Mar 2016; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT02484001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484001.